Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04782687
Title Phase II Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors US Oncology Research
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Arizona Oncology Associates, PC - HOPE RECRUITING Tucson Arizona 85711 United States Details
Rocky Mountain Cancer Centers RECRUITING Denver Colorado 80218 United States Details
Maryland Oncology Hematology, P.A. RECRUITING Columbia Maryland 21044 United States Details
New York Oncology Hematology, P.C. RECRUITING Albany New York 12206 United States Details
Willamette Valley Cancer Institute and Research Center NOT_YET_RECRUITING Eugene Oregon 97401 United States Details
Texas Oncology, P.A. NOT_YET_RECRUITING Austin Texas 78705 United States Details
Texas Oncology, P.A. NOT_YET_RECRUITING Fort Worth Texas 76104 United States Details
Texas Oncology, P.A. NOT_YET_RECRUITING San Antonio Texas 78240 United States Details
Texas Oncology, P.A. NOT_YET_RECRUITING Tyler Texas 75702 United States Details
Virginia Cancer Specialists, PC RECRUITING Gainesville Virginia 20155 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field